期刊文献+

弓形虫可溶性抗原联合γ干扰素鼻内免疫小鼠的抗弓形虫感染作用 被引量:16

Intranasal immunization with STAg and IFN-γ produces protection against Toxoplasma gondii in mice
暂未订购
导出
摘要 目的探讨弓形虫可溶性抗原(STAg)和γ干扰素(IFN-γ)联合鼻内免疫对小鼠的保护作用及IFN-γ作为佐剂鼻内免疫抗弓形虫感染的最佳剂量.方法将5~6周龄BALB/c小鼠70只随机分为5组,每组14只,分别用20μg STAg、20μg STAg+250 U IFN-γ、20 μg STAg+500 UIFN-γ、20μg STAg+1 000 U IFN-γ和20μg STAg+2 000 U IFN-γ鼻内免疫小鼠2次,间隔14 d,末次免疫后第10天,用RH株弓形虫速殖子4×104个/只灌胃攻击,逐日观察小鼠健康存活情况.攻击后第29天处死全部小鼠,分离计数脑、肝组织速殖子;计数肠系膜淋巴结(MLN)和脾T淋巴细胞.结果随着佐剂IFN-γ剂量的增加,小鼠存活率有升高趋势,1 000 U IFN-γ剂量组小鼠存活率最高达93%;肝、脑速殖子数呈下降的趋势,其中STAg+1 000 U IFN-γ、STAg+2 000 UIFN-γ组显著低于STAg组;MLN和脾T淋巴细胞发生了增殖性应答,其中STAg+1 000 UIFN-γ、STAg+2 000 U IFN-γ组MLN细胞显著高于STAg组.结论STAg+1 000 U IFN-γ、STAg+2 000 U IFN-γ鼻内免疫明显优于其它小剂量佐剂及单独抗原免疫,能有效诱导黏膜免疫应答. Objective To investigate the protective effect against Toxoplasma gondii infection following intranasally administered mice with STAg and gamma interferon (IFN-γ), and determine the optimal dose of IFN-γ as adjuvant for intranasal immunization. Methods Seventy 5- to 6-week-old BALB/c mice were randomly divided into five groups, fourteen mice of each group were immunized intranasally two times at 14-day intervals with 20μg STAg alone, 20μg STAg plus 250 UIFN-γ, 20μg STAg plus 500 U IFN-γ, 20μg STAg plus 1 000 U IFN-γ or 20μg STAg plus 2 000U IFN-γ. The PBS containing 4×10^4 tachyzoites of RH strain in each 0.5 ml volume were orally administered to all animals on Day 10 after the last immunization. The healthy and survival of mice were observed day by day. Survivors were sacrificed on Day 29 after infection, the tachyzoites in livers and brains were counted, the number of MLN and spleen T lymphocytes were determined.Results The 'survival rate of mice rised with the increasing dose of IFN-γ. The survival rate of STAg plus 1 000 U IFN-γ group was 93%, which was the highest among the groups. The tachyzoites had an incline to decrease, which were significantly smaller in the groups of STAg plus 1 000 U IFN-γ or STAg plus 2 000 U than those of STAg groups (P〈0.05). Proliferative responses were observed in MLN and spleen T lymphocytes, and the MLN cells in the groups of STAg plus 1 000 U IFN-γ and STAg plus 2 000 U were obviously higher than those of STAg groups (P〈0.01). Conclusion Intranasal immunization of STAg plus 1 000 U IFN-γ and STAg plus 2 000 U is prior to other groups, which induced mucosal immune response effectively.
出处 《中国血吸虫病防治杂志》 CAS CSCD 2005年第4期293-297,共5页 Chinese Journal of Schistosomiasis Control
基金 山西省自然科学基金(No.20041105) 山西省高校科技研究开发项目(No.20041238) 山西医科大学基础医学院学科研究方向建设基金(20040708)
关键词 弓形虫可溶性抗原 γ 干扰素 弓形虫 鼻内免疫 黏膜免疫 Soluble Toxoplasrna antigen Gamma interferon Toxoplasma gondii Intranasal immunization Mucosal immunization
  • 相关文献

参考文献21

  • 1韩剑峰,殷国荣,刘红丽,申金雁,元海军,沈嬿琼.经口感染弓形虫BALB/c小鼠血清及肠道分泌物中IgA抗体含量的检测[J].热带医学杂志,2004,4(1):19-21. 被引量:18
  • 2Iijima H, Takahashi I, Kiyono H. Mucosal immune network in the gut for the control of infectious diseases [J]. Rev Med Virol, 2001, 11(2):117-133.
  • 3殷国荣,元海军,杨亚波,周永安,沈嬿琼,孟晓丽.TSo联合IFN-γ鼻内免疫小鼠诱导的弓形虫IgA抗体特异性免疫应答[J].热带医学杂志,2004,4(6):670-673. 被引量:25
  • 4Smith NC. Concepts and strategies for anti-parasite immunoprophylaxis and therapy [J]. Int Parasitol, 1992, 22 (8): 1047-1082.
  • 5Suzuki Y. IFN-γ: the major mediator of resistance against Toxoplasma gondii [J]. Science, 1988, 240(2): 516-523.
  • 6Czerklett C, Anjuere F, Mcgbee JR, et al. Mucosal immunity and tolerance: relevance to vaccine development [J]. Immunol Rev, 1999, 170: 197-222.
  • 7Velge-Roussel F, Marcelo P, Bout DT, et al. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments [J]. Infect Immun,2000, 68 (2): 969-972.
  • 8Bonenfant C, Dimier-Poisson I, Velge-Roussel F, et al. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii [J].Infect Immun, 2001, 69(4): 1605-1612.
  • 9Lieberman LA, Hunter CA. The role of cytokines and their signaling pathways in the regulation of immunity to Toxoplasma gondii [J]. Int Rev Immunol, 2002, 21(4-5) :373-403.
  • 10Yano A, Mun HS, Chin M, et al. Roles of IFN-gamma on stage conversion of an obligate intracellular protozoan parasite,Toxoplasma gondii [J]. Int Rev Immunol, 2002, 21 (4-5):405-421.

二级参考文献17

  • 1Halina Wedrychowicz,舒衡平.胃肠道寄生虫感染中的分泌型IgA[J].国外医学(寄生虫病分册),1996,23(4):156-158. 被引量:2
  • 2汤一苇.疫苗佐剂研究进展[J].国外医学(预防.诊断.治疗用生物制品分册),1996,19(3):107-110. 被引量:8
  • 3[4]Iijima H, Takahashi I, Kiyono H. Mucosal immune network in the gut for the control of infectious diseases[J]. Rev Med Virol, 2001, 11(2): 117- 133.
  • 4[5]Lloyd Kaspera, Nathalie Courretb, Sylvie Darchec, et al. Toxoplasma gondii and mucosal immunity[J]. Int J for Parasitol,2004, 34:401- 409.
  • 5[6]Briskin M, Winsor HD, Shyjan A, et al. Human mucosal addressin cell adhesion molecule is preferentially expressed in intestinal tract and associated lymphoid tissue [J]. Am J Pathol, 1997, 151:97- 110.
  • 6[7]Suzuki Y. IFN-γ : the major mediator of resistance against Toxoplasma gondii [J]. Science, 1988, 240:516- 523.
  • 7[9]Debard N, Buzoni- Gatel D, Bout D. Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebal cyst after oral infection[J]. Infect Immun, 1996, 64 (6): 2158- 2166.
  • 8[10]Velge- Roussel F, Marcelo P, Bout DT, et al. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments[J]. Infect Immun, 2000, 68 (2): 969- 972.
  • 9[11]Bonenfant C, Dimier- Poisson I, Velge- Roussel F, et al. Intranasal I immunization with SAG1 and nontoxic mutant heat- labile enterotoxins protects mice against Toxoplasma gondii [J]. Infect Immun, 2001, 69(4): 1605- 1612.
  • 10[13]Chardes T, Bourguin I, Mevelec MN, et al. Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens[J]. Infect Immun, 1990, 58(5):1240- 1246.

共引文献46

同被引文献224

引证文献16

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部